A detailed history of Invesco Ltd. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 15,324 shares of CABA stock, worth $69,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,324
Previous 744,777 97.94%
Holding current value
$69,111
Previous $12.7 Million 99.1%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$7.22 - $18.82 $5.27 Million - $13.7 Million
-729,453 Reduced 97.94%
15,324 $114,000
Q1 2024

May 14, 2024

SELL
$16.79 - $25.38 $11 Million - $16.6 Million
-653,165 Reduced 46.72%
744,777 $12.7 Million
Q4 2023

Feb 12, 2024

BUY
$12.21 - $23.36 $6.64 Million - $12.7 Million
543,899 Added 63.69%
1,397,942 $31.7 Million
Q3 2023

Nov 13, 2023

SELL
$11.84 - $18.65 $33,696 - $53,077
-2,846 Reduced 0.33%
854,043 $13 Million
Q2 2023

Aug 11, 2023

BUY
$7.65 - $13.95 $6.56 Million - $12 Million
856,889 New
856,889 $11.1 Million

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $131M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.